Dr. Booth-Jones' clinical interests are cognitive changes in cancer patients and their subsequent impact on psychosocial function and emotional well-being. She is an Assistant Professor of Oncology and Psychiatry at the University of South Florida and a Neuropsychologist in the Supportive Care Program at Moffitt Cancer Center & Research Institute.
Education & Training
- University of Florida - Clinical and Health Psychology
- University of Chicago Medical Center - Psychiatry
- University of Florida - PhD
- Hyland KA, Eisel SL, Hoogland AI, Root JC, Bowles K, James B, Nelson AM, Booth-Jones M, Jacobsen PB, Ahles TA, Jim HSL, Gonzalez BD. Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison. Leuk Lymphoma. 2023 Feb.64(2):415-423. Pubmedid: 36476293.
- Hoogland AI, Barata A, Logue J, Kommalapati A, Hyland KA, Nelson AM, Eisel SL, Small BJ, James BW, Christy SM, Bulls HW, Booth-Jones M, Jayani RV, Jain MD, Mokhtari S, Chavez JC, Lazaryan A, Shah BD, Locke FL, Jim HSL. Change in Neurocognitive Performance Among Patients with Non-Hodgkin Lymphoma in the First Year after Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2022 Jun.28(6):305.e1-305.e9. Pubmedid: 35378330. Pmcid: PMC9197947.
- Barata A, Hoogland AI, Kommalapati A, Logue J, Welniak T, Hyland KA, Eisel SL, Small BJ, Jayani RV, Booth-Jones M, Oswald LB, Gonzalez BD, Kirtane KS, Jain MD, Mokhtari S, Chavez JC, Lazaryan A, Shah BD, Locke FL, Jim HSL. Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma. Transplant Cell Ther. 2022 Jul.28(7):401.e1-401.e7. Pubmedid: 35580732. Pmcid: PMC9339228.
- Hoogland AI, Jayani RV, Collier A, Irizarry-Arroyo N, Rodriguez Y, Jain MD, Booth-Jones M, Hyland KA, James BW, Barata A, Bachmeier CA, Chavez JC, Khimani F, Krivenko GS, Lazaryan A, Liu HD, Nishihori T, Pinilla-Ibarz J, Shah BD, Abidi M, Locke FL, Jim HSL. Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel. Cancer Med. 2021 Mar.10(6):1936-1943. Pubmedid: 33641257. Pmcid: PMC7957158.
- Hernandez J, Lubrano di Ciccone B, Thirlwell S, Booth-Jones M, Aslam S, Greene J. COVID-19 pandemic causing medical and public health ethical dilemmas: A case report and review of literature. Qual Res Med Healthc. 2021 Mar.5(1).
- Barata A, Hoogland AI, Hyland KA, Otto AK, Kommalapati A, Jayani RV, Irizarry-Arroyo N, Collier A, Rodriguez Y, Welniak TL, Booth-Jones M, Logue J, Small BJ, Jain MD, Reblin M, Locke FL, Jim HSL. Quality of life in caregivers of patients receiving chimeric antigen receptor T-cell therapy. Psychooncology. 2021 Aug.30(8):1294-1301. Pubmedid: 33739548. Pmcid: PMC9828891.
- Barata A, Gonzalez BD, Zhou JM, Kim J, Hoogland AI, El-Jawahri A, Booth-Jones M, Jim HSL. Associations among depression, antidepressants, survival and quality of life in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2020 Sep.55(9):1868-1871. Pubmedid: 32398786. Pmcid: PMC7968382.
- Hoogland AI, Nelson AM, Gonzalez BD, Small BJ, Breen EC, Sutton SK, Syrjala KL, Bower JE, Pidala J, Booth-Jones M, Jacobsen PB, Jim HSL. Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation. Brain Behav Immun. 2019 Aug.80:308-314. Pubmedid: 30953767. Pmcid: PMC6660393.
- Hoogland AI, Nelson AM, Small BJ, Hyland KA, Gonzalez BD, Booth-Jones M, Anasetti C, Jacobsen PB, Jim HSL. The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Tr. 2017 Nov.23(11):1974-1979. Pubmedid: 28797784. Pmcid: PMC5682195.
- Gonzalez BD, Jim HS, Booth-Jones M, Small BJ, Sutton SK, Lin HY, Park JY, Spiess PE, Fishman MN, Jacobsen PB. Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled Comparison. J Clin Oncol. 2015 Jun.33(18):2021-2027. Pubmedid: 25964245. Pmcid: PMC4461804.
- Brem S, Meyers CA, Palmer G, Booth-Jones M, Jain S, Ewend MG. Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers. Cancer. 2013 Nov.119(21):3830-3838. Pubmedid: 24037801. Pmcid: PMC4209121.
- Jim HS, Small B, Hartman S, Franzen J, Millay S, Phillips K, Jacobsen PB, Booth-Jones M, Pidala J. Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation. Cancer. 2012 Jul.118(13):3407-3416. Pubmedid: 22139882. Pmcid: PMC3297700.
- Jim HS, Boyd TD, Booth-Jones M, Pidala J, Potter H. Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients. Brain Disord Ther. 2012.1(1). Pubmedid: 22905341. Pmcid: PMC3422132.
- Wells KJ, Booth-Jones M, Jacobsen PB. Do coping and social support predict depression and anxiety in patients undergoing hematopoietic stem cell transplantation?. J Psychosoc Oncol. 2009.27(3):297-315. Pubmedid: 19544178. Pmcid: PMC3866098.
- Gross-King M, Booth-Jones M, Couluris M. Neurocognitive impairment in children treated for cancer: how do we measure cognitive outcomes?. J Pediatr Oncol Nurs. 2008 Sep.25(4):227-232. Pubmedid: 18559886.
- Jacobs S, Small B, Booth-Jones M, Jacobsen P, Fields K. Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer. 2007 Oct.110(7):1560-1567. Pubmedid: 17685391.
- Jacobs S, Jacobsen P, Booth-Jones M, Wagner L, Anasetti C. Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients. J Pain Symptom Manag. 2007 Jan.33(1):13-23. Pubmedid: 17196903.
- Ransom S, Jacobsen P, Booth-Jones M. Validation of the Distress Thermometer with bone marrow transplant patients. Psychooncology. 2006 Jul.15(7):604-612. Pubmedid: 16208733.
- Fox S, Mitchell S, Booth-Jones M. Cognitive impairment in patients with brain tumors: assessment and intervention in the clinic setting. Clin J Oncol Nurs. 2006 Apr.10(2):169-176. Pubmedid: 16708701.
- Booth-Jones M, Jacobsen P, Ransom S, Soety E. Characteristics and correlates of cognitive functioning following bone marrow transplantation. Bone Marrow Transplant. 2005 Oct.36(8):695-702. Pubmedid: 16086044.
- Extermann M, Chen H, Booth-Jones M, Meyer J, Balducci L, Jacobsen P. Pilot testing of the computerized cognitive test Microcog in chemotherapy-treated older cancer patients. Crit Rev Oncol Hematol. 2005 May.54(2):137-143. Pubmedid: 15843096.
- Widows M, Jacobsen P, Booth-Jones M, Fields K. Predictors of posttraumatic growth following bone marrow transplantation for cancer. Health Psychol. 2005 May.24(3):266-273. Pubmedid: 15898862.
- Weitzner M, Kanfer S, Booth-Jones M. Apathy and pituitary disease: it has nothing to do with depression. J Neuropsychiatry Clin Neurosci. 2005 Apr.17(2):159-166. Pubmedid: 15939968.
- Jacobsen P, Garland L, Booth-Jones M, Donovan K, Thors C, Winters E, Grendys E. Relationship of hemoglobin levels to fatigue and cognitive functioning among cancer patients receiving chemotherapy. J Pain Symptom Manag. 2004 Jul.28(1):7-18. Pubmedid: 15223080.
- Sadler I, Jacobsen P, Booth-Jones M, Belanger H, Weitzner M, Fields K. Preliminary evaluation of a clinical syndrome approach to assessing cancer-related fatigue. J Pain Symptom Manag. 2002 May.23(5):406-416. Pubmedid: 12007758.
- Jacobsen PB, Sadler IJ, Booth-Jones M, Soety E, Weitzner MA, Fields KK. Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. J Consult Clin Psychol. 2002 Feb.70(1):235-240. Pubmedid: 11860050.
Patient CommentsOverall Satisfaction4.9
159 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.Learn more about our patient satisfaction survey
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
- The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
- He or she may be a researcher or other type of provider that does not see patients.
- The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.